Sales Growth YoY (Last Twelve Months): Spruce Biosciences Inc. (SPRB)

Graphic logo of Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences (SPRB) maintains its resilience through patents on tildersifern, which create significant barriers to entry for competitors. The historical year-over-year revenue growth trend over the last 12 months confirms this potential, while -100.00 determines the current magnitude of this metric. Research and development in rare endocrine pathologies rely on US centers, and a neutral geopolitical backdrop ensures the stability of clinical trials.

Sales Growth YoY (Last Twelve Months): Spruce Biosciences, Inc. (SPRB) for 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Spruce Biosciences Inc. (SPRB)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Spruce Biosciences Inc., SPRB
Mass-produced product of Spruce Biosciences, Inc.

To minimize risks when establishing a long-term position, it is critical to track real product demand via year-over-year sales dynamics using the TTM methodology, which filters out market noise. For Spruce Biosciences (SPRB), this indicator measures the monetization efficiency of orphan drugs, confirming the ability of R&D investments to generate operating leverage and fundamental business stability.

Competitors of Spruce Biosciences (SPRB)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Trailing Twelve Months Revenue Growth|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)